Corpus Intelligence IC Memo — OWATONNA HOSPITAL 2026-04-26 14:21 UTC
IC Memo — OWATONNA HOSPITAL
Investment Committee Memorandum | MN | 29 beds | Grade C | EBITDA uplift $4.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OWATONNA HOSPITAL

CCN 240069 | STEELE, MN | 29 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OWATONNA HOSPITAL is a 29-bed suburban community hospital in STEELE, MN with $57.9M in net patient revenue and a -7.7% operating margin. The hospital serves a payer mix of 30.0% Medicare, 10.4% Medicaid, and 59.6% commercial.

Thesis: Turnaround. Our ML models identify $4.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.7% to -0.4% (+736bps).

Net Revenue HCRIS$57.9M
Current EBITDA COMPUTED$-4.5M
Operating Margin COMPUTED-7.7%
Occupancy HCRIS53.6%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS36.8%
Distress Probability ML48.3%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
86
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -7.7% places it below the state median. Among 86 size-comparable peers (14-58 beds), the median margin is -2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-58), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OWATONNA HOSPITAL (Target)MN29$57.9M-7.7%
CUYUNA REGIONAL MEDICAL CENTERMN25$180.8M-4.0%
ST. MARYS REGIONAL HEALTH CENTMN36$167.8M3.1%
MAYO CLINIC HEALTH SYSTEM - REMN27$149.3M1.8%
ESSENTIA HEALTH VIRGINIAMN49$132.0M-5.0%
NEW ULM MEDICAL CENTERMN24$128.6M4.2%
LAKEWOOD HEALTH SYSTEMMN25$124.7M0.2%
NORTHFIELD CITY HOSPITALMN37$121.8M-8.4%
FAIRVIEW LAKES REGIONAL MEDICAMN55$119.6M10.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$704K+122bp9mo
Clean Claim Rate88.0%96.0%$37K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.2M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$704K
Clean Claim Rate
$37K
Total EBITDA Uplift$4.3M
Current EBITDA$-4.5M
+ RCM Uplift+$4.3M
Pro Forma EBITDA$-223K
Current Margin-7.7%
Pro Forma Margin-0.4%
WC Released (1x)$2.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.9M$13.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.9M$12.1M0.00x-100.0%
Bull Case9.0x11.0x$-6.2M$23.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.2M$24.3M0.00x-100.0%
Bear Case11.0x10.0x$-7.6M$-6.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.6M$-9.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 14-58 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-10.6% / P50=-2.0% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.